7 day stay, 2 Appointments

Help Test a New Potential Prevention for Sore Throat

Apply Now

Why this clinical trial matters

Something as easily treatable as a sore throat caused by Streptococcus A (Strep Throat) can have complications for those with less access to healthcare, including Aboriginal people in remote areas.

Repeated Strep A infections and repeated attacks of rheumatic fever during childhood and adolescence can damage the valves in the heart leading to rheumatic heart disease (RHD). Decisions about managing the disease during childhood and teenage years can also have lifelong consequences for women who want families.

About the controlled clinical trial

A Strep A infection that results in RHD would only usually be expected in cases where treatments (such as those in our clinical trial) are not routinely administered.

The findings from the Sore Throat Trial will inform treatments that deliver better health outcomes for thousands of children and may contribute to closing the health gap and average life expectancy for Aboriginal people.

What the trial involves

The controlled health study will be trialling better modality and formulation of penicillin to provide a practical, less painful method of treatment and protection. This will vastly increase the number of patients successfully managed to prevent acute rheumatic fever from developing into rheumatic heart disease.

State-of-the-art Joondalup Campus

Linear has recently opened a new clinical research facility in Joondalup, where this study will be conducted. A sister campus to our long-established Perth facility, Joondalup is fully equipped with outstanding amenities for the comfort and safety of trial volunteers.


Cohort 2.4

7 Day Clinic Stay

Check In Jan 16th
Check Out Jan 22nd

2 Appointments

To be scheduled during in-clinic stay